... Management LLC bought a new position in shares of CymaBay Therapeutics during the 3rd quarter valued at $404,000. Ardsley Advisory Partners lifted its holdings in shares of CymaBay Therapeutics by 66.2% during the 2nd quarter. Ardsley Advisory ...
https://www.chaffeybreeze.com/2018/01/22/cymabay-therapeutics-inc-cbay-expected-to-post-quarterly-sales-of-6-75-million.html
No comments:
Post a Comment